Your browser doesn't support javascript.
loading
Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
Kunisaki, Ken M; Niewoehner, Dennis E; Collins, Gary; Aagaard, Bitten; Atako, Nafisah B; Bakowska, Elzbieta; Clarke, Amanda; Corbelli, Giulio Maria; Ekong, Ernest; Emery, Sean; Finley, Elizabeth B; Florence, Eric; Infante, Rosa M; Kityo, Cissy M; Madero, Juan Sierra; Nixon, Daniel E; Tedaldi, Ellen; Vestbo, Jørgen; Wood, Robin; Connett, John E.
Afiliação
  • Kunisaki KM; Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA; University of Minnesota, Minneapolis, MN, USA. Electronic address: kunis001@umn.edu.
  • Niewoehner DE; Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA; University of Minnesota, Minneapolis, MN, USA.
  • Collins G; University of Minnesota, Minneapolis, MN, USA.
  • Aagaard B; Copenhagen HIV Programme, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Atako NB; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Bakowska E; Wojewodzki Szpital Zakazny, Warsaw, Poland.
  • Clarke A; Royal Sussex County Hospital, Brighton, UK.
  • Corbelli GM; European AIDS Treatment Group, Rome, Italy.
  • Ekong E; Institute of Human Virology-Nigeria, Abuja, Nigeria.
  • Emery S; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
  • Finley EB; Washington DC Veterans Affairs Medical Center, Washington, DC, USA.
  • Florence E; Institute of Tropical Medicine, Antwerp, Belgium.
  • Infante RM; Asociación Civil Impacta Salud y Educación, Barranco, Lima, Perú.
  • Kityo CM; Joint Clinical Research Centre, Kampala, Uganda.
  • Madero JS; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Infectious Diseases Department, Mexico City, Mexico.
  • Nixon DE; Virginia Commonwealth University, Richmond, VA, USA.
  • Tedaldi E; Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Vestbo J; University of Manchester, Manchester, UK.
  • Wood R; Desmond Tutu HIV Foundation, Cape Town, South Africa.
  • Connett JE; University of Minnesota, Minneapolis, MN, USA.
Lancet Respir Med ; 4(12): 980-989, 2016 12.
Article em En | MEDLINE | ID: mdl-27773665
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Soropositividade para HIV / Fármacos Anti-HIV / Tempo para o Tratamento Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Respir Med Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Soropositividade para HIV / Fármacos Anti-HIV / Tempo para o Tratamento Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Respir Med Ano de publicação: 2016 Tipo de documento: Article